Coronary CTA exposes plaque risk for diabetics

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 12
Volume 31
Issue 12

Findings from a large multicenter study suggest 64-slice CT angiography is better suited than other cardiac diagnostic tests for detecting clinically relevant coronary artery plaques in patients with diabetes.

Findings from a large multicenter study suggest 64-slice CT angiography is better suited than other cardiac diagnostic tests for detecting clinically relevant coronary artery plaques in patients with diabetes.

Dr. Fay Y. Lin, an associate professor of medicine at Cornell University, and colleagues prospectively evaluated a cohort of 3926 patients with symptomatic cardiovascular disease, Lin determined that 727 had diabetes. All patients underwent coronary 64-slice CTA between 2005 and 2007. Researchers found that patients with diabetes faced twice the risk of dying from a cardiac-related problem within two years of diagnosis as nondiabetic patients. CTA more accurately characterized plaque burden than alternative modalities for patients with low calcium score or normal stress testing results. Lin reported the findings at the 2009 Society of Cardiovascular Computed Tomography meeting.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
A Closer Look at the Impact of Expanded Mammography Coverage in Missouri: An Interview with Amy Patel, MD
New Mammography Research Examines Impact of High-Resolution DBT
Can Radioligand Therapy Have an Impact for Women with Breast Cancer?
Emerging Concepts in CT-Guided Treatment of Coronary Artery Disease
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.